Review Article Tissue-engineered skin: bottleneck or breakthrough

Sha Huang,Xiaobing Fu,P. China

2011-01-01

Abstract:Introduction The need is great for safe and effective thera-peutic options for wound coverage and tissue repair in diverse clinical settings, such as in acute skin wounds, burns and chronic skin ul-cers, which represent a major burden on world health care costs. Autografting with split-thickness skin is the preferred treatment for coverage of excised burn wounds, but donor sites for autografting are limited in patients with very large burns. In these patients, wound cov-erage requires repeated harvesting of available donor sites, which is associated with pain and scarring at the donor site and lengthy hospital stays. Moreover, in the developed world, life expectancy and affluence have increased so markedly that chronic wound associated with aging and diabetes has become significant. The traditional treatment of relatively small chronic wounds has included the use of topical agents and grafting of split- or full-thickness skin. Skin grafts can provide timely wound coverage but may lead to painful donor sites, which are slow to heal and may be unsuccessful because of underlying deficiencies in wound healing [1]. As well, although congenital skin conditions and diseases affect a relatively small fraction of the population, they represent significant chal-lenges for wound coverage [2]. Because of the limited use of autografts and allografts and the large medical need for wound coverage in these diverse patient populations，bioengineered skin has been developed to pro-vide new alternatives for clinicians to restore various skin defects. Over the last 30 years, bioengineered skin research, as one of the most active fields in biological substitutes, has ex-tended the prospects for improving outcomes for patients with acute and chronic skin wounds. The first-documented bioengineered skin product, cultured epithelial autografts, ap-peared 30 years ago. Rheinwald and Green iso-lated and cultured keratinocytes from skin, which was further developed into small sheets of cells, two or three cell-layers thick [3]. Evi-dence suggests that cultured skin cells returned to a patient retain the capacity to self-renew for a lifetime [4]. However, delivering keratinocytes as small sheets is problematic. The sheets are fragile, and many of the keratinocytes are al-ready differentiated beyond the point to which they can take any active part in providing a new epithelium. Hence, the company Genzyme fur-ther created living epithelial sheets with this Int J Burn Trauma 2011;1(1):1-10 www.IJBT.org /ISSN: 2160-2026/IJBT1106001